HEALTHKTLA 5
FDA panel votes to add peptides to permitted list despite opposition from agency scientists
The FDA's committee on compounded drugs voted to add peptides to the list of substances compounding pharmacies can make, despite opposition from agency scientists who raised concerns about the lack of demonstrated benefits.
Mentioned
Related Signal
Adjacent reporting
- FDA panel votes to add peptides to permitted compounding list despite opposition from agency scientists
- FDA panel backs easier access to peptides
- FDA advisory committee votes to add popular peptide BPC-157 to drug compounding list
- FDA panel narrowly backs unapproved peptide drug touted by Joe Rogan and other influencers